H. Al-attrache, A. Sharanek, A. Burban, M. Burbank, T. Gicquel et al., Differential sensitivity of metabolically competent and non-competent HepaRG cells to apoptosis induced by diclofenac combined or not with TNF-alpha, Toxicology letters, vol.258, pp.71-86, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01372855

C. Aninat, P. Seguin, P. N. Descheemaeker, F. Morel, Y. Malledant et al., Catecholamines induce an inflammatory response in human hepatocytes, Crit Care Med, vol.36, pp.848-854, 2008.

S. Antherieu, P. Bachour-el-azzi, J. Dumont, Z. Abdel-razzak, C. Guguen-guillouzo et al., Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells, Hepatology, vol.57, pp.1518-1529, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00865999

P. Bachour-el-azzi, A. Sharanek, Z. Abdel-razzak, S. Antherieu, H. Al-attrache et al., Impact of inflammation on chlorpromazine-induced cytotoxicity and cholestatic features in HepaRG cells. Drug metabolism and disposition: the biological fate of chemicals, vol.42, pp.1556-1566, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01134764

K. M. Beggs, A. M. Fullerton, K. Miyakawa, P. E. Ganey, and R. A. Roth, Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction, Toxicol Sci, vol.137, pp.91-101, 2014.

J. J. Broeders, C. Parmentier, G. L. Truisi, R. Josse, E. Alexandre et al., Biokinetics of chlorpromazine in primary rat and human hepatocytes and human HepaRG cells after repeated exposure, Toxicology in vitro : an international journal published in association with BIBRA, vol.30, pp.52-61, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01128186

A. Burban, A. Sharanek, C. Guguen-guillouzo, and A. Guillouzo, Endoplasmic reticulum stress precedes oxidative stress in antibiotic-induced cholestasis and cytotoxicity in human hepatocytes, Free radical biology & medicine, vol.115, pp.166-178, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01671714

A. Burban, A. Sharanek, R. Hue, M. Gay, S. Routier et al., Penicillinase-resistant antibiotics induce non-immune-mediated cholestasis through HSP27 activation associated with PKC/P38 and PI3K/AKT signaling pathways, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01522586

A. Burban, A. Sharanek, L. Humbert, T. Eguether, C. Guguen-guillouzo et al., Predictive Value of Cellular Accumulation of Hydrophobic Bile Acids as a Marker of Cholestatic Drug Potential, Toxicological sciences : an official journal of the Society of Toxicology, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02020472

S. Y. Cai, X. Ouyang, Y. Chen, C. J. Soroka, J. Wang et al., Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response, JCI insight, vol.2, 2017.

V. Cerec, D. Glaise, D. Garnier, S. Morosan, B. Turlin et al., Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor, Hepatology, vol.45, pp.957-967, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00690471

N. Chand and A. J. Sanyal, Sepsis-induced cholestasis, Hepatology, vol.45, pp.230-241, 2007.

B. D. Cosgrove, B. M. King, M. A. Hasan, L. G. Alexopoulos, P. A. Farazi et al., Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity, Toxicology and applied pharmacology, vol.237, pp.317-330, 2009.

L. Diao, N. Li, T. G. Brayman, K. J. Hotz, and Y. Lai, Regulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-{alpha}, IL-6, and IL-1{beta}, J Biol Chem, vol.285, pp.31185-31192, 2010.

M. G. Elferink, P. Olinga, A. L. Draaisma, M. T. Merema, K. N. Faber et al., LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process, American journal of physiology Gastrointestinal and liver physiology, vol.287, pp.1008-1016, 2004.

O. Fardel and M. Le-vee, Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines, Expert opinion on drug metabolism & toxicology, vol.5, pp.1469-1481, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00673340

L. Fredriksson, S. Wink, B. Herpers, G. Benedetti, M. Hadi et al., Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFalpha-mediated hepatotoxicity, Toxicological sciences : an official journal of the Society of Toxicology, vol.140, pp.144-159, 2014.

P. R. Galle, L. Theilmann, R. Raedsch, G. Otto, and A. Stiehl, Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes, Hepatology, vol.12, pp.486-491, 1990.

P. E. Ganey, J. P. Luyendyk, J. F. Maddox, and R. A. Roth, Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor, Chemicobiological interactions, vol.150, pp.35-51, 2004.

A. Guillouzo and C. Guguen-guillouzo, HepaRG Cells as a Model for Hepatotoxicity Studies, Stem cells in toxicology and teratology, pp.309-339, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01875339

H. Hao, L. Cao, C. Jiang, Y. Che, S. Zhang et al., Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis, Cell metabolism, vol.25, pp.856-867, 2017.

M. Klein, M. Thomas, U. Hofmann, D. Seehofer, G. Damm et al., A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG cells, Drug Metab Dispos, vol.43, pp.273-283, 2015.

D. Larrey, C. Funck-brentano, P. Breil, J. Vitaux, C. Theodore et al., Effects of erythromycin on hepatic drug-metabolizing enzymes in humans, Biochem Pharmacol, vol.32, pp.1063-1068, 1983.

L. Vee, M. Lecureur, V. Stieger, B. Fardel, and O. , Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug metabolism and disposition: the biological fate of chemicals, vol.37, pp.685-693, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00673249

C. Levine, A. Trivedi, S. N. Thung, and P. V. Perumalswami, Severe ductopenia and cholestasis from levofloxacin drug-induced liver injury: a case report and review, Seminars in liver disease, vol.34, pp.246-251, 2014.

A. R. Maiuri, A. B. Breier, L. F. Gora, R. V. Parkins, P. E. Ganey et al., Cytotoxic Synergy Between Cytokines and NSAIDs Associated With Idiosyncratic Hepatotoxicity Is Driven by Mitogen-Activated Protein Kinases, Toxicol Sci, vol.146, pp.265-280, 2015.

G. Pomponio, C. C. Savary, C. Parmentier, F. Bois, A. Guillouzo et al., In vitro kinetics of amiodarone and its major metabolite in two human liver cell models after acute and repeated treatments, Toxicology in vitro : an international journal published in association with BIBRA, vol.30, pp.36-51, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01134698

R. A. Roth, A. R. Maiuri, and P. E. Ganey, Idiosyncratic Drug-Induced Liver Injury: Is Drug-Cytokine Interaction the Linchpin?, The Journal of pharmacology and experimental therapeutics, vol.360, pp.461-470, 2017.

K. Rubin, A. Janefeldt, L. Andersson, Z. Berke, K. Grime et al., HepaRG cells as human-relevant in vitro model to study the effects of inflammatory stimuli on cytochrome P450 isoenzymes, Drug Metab Dispos, vol.43, pp.119-125, 2015.

S. Russmann, J. A. Kaye, S. S. Jick, and H. Jick, Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database, Br J Clin Pharmacol, vol.60, pp.76-82, 2005.

A. Sharanek, A. Burban, M. Burbank, R. Le-guevel, R. Li et al., Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01326368

A. Sharanek, A. Burban, L. Humbert, P. Bachour-el-azzi, N. Felix-gomes et al., Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes, Toxicological sciences : an official journal of the Society of Toxicology, vol.147, pp.573-587, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01187306

A. Sharanek, A. Burban, L. Humbert, C. Guguen-guillouzo, D. Rainteau et al., Progressive and Preferential Cellular Accumulation of A, 2017.

, Hydrophobic Bile Acids Induced by Cholestatic Drugs Is Associated with Inhibition of Their Amidation and Sulfation. Drug metabolism and disposition: the biological fate of chemicals 45, pp.1292-1303

P. J. Shaw, P. E. Ganey, and R. A. Roth, Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity, Toxicological sciences : an official journal of the Society of Toxicology, vol.118, pp.7-18, 2010.

B. L. Woolbright and H. Jaeschke, Novel insight into mechanisms of cholestatic liver injury, World journal of gastroenterology, vol.18, pp.4985-4993, 2012.

B. L. Woolbright and H. Jaeschke, Therapeutic targets for cholestatic liver injury, Expert opinion on therapeutic targets, vol.20, pp.463-475, 2016.

H. Yamazaki, T. Urano, S. Hiroki, and T. Shimada, Effects of erythromycin and roxithromycin on oxidation of testosterone and nifedipine catalyzed by CYP3A4 in human liver microsomes, The Journal of toxicological sciences, vol.21, pp.215-226, 1996.